Abstract Case Report
gradually improved and diabetic ketoacidosis resolved over 36 h. However, pain abdomen persisted. Ultrasound abdomen revealed bulky pancreas. The child was continued on injection insulin, intravenous fluids for further 48 h. Pain abdomen improved and serum TG and cholesterol showed a decreasing trend [ Table 1 ]. Repeat HbA1c at discharge was 14.2%. Serum C-peptide was low <0.3 ng/ml (0.81-3.85) and insulin antibodies were positive by enzyme immunoassay. The child was started on oral feeding and subcutaneous insulin. She was discharged 8 days after hospitalization. During follow-up, her lipid profile remained normal.
dIScuSSIon
This case highlights the challenges faced during management of severe diabetic ketoacidosis complicated by severe hypertriglyceridemia and resulting in acute pancreatitis. Our case presented with encephalopathy and possibility of cerebral edema, shock encephalopathy, or electrolyte disturbances was considered. Rapid improvement in Glasgow Coma Scale with volume resuscitation made strong possibility of shock encephalopathy as likely etiology. An important problem faced was an interpretation of laboratory measurements due to lipemic sample. Severe lipemia interferes with clinical laboratory testing through three mechanisms: (1) turbidity resulting in light scattering, (2) an increase in the nonaqueous phase of the sample, and (3) partitioning between the polar and nonpolar phases. Laboratory results were ambiguous in the case such as hemoglobin 24.7 mg% and HbA1c value of just 7.8%. Serum electrolytes could be ascertained after 12 h which has an important bearing as serum corrected sodium needs to be monitored to prevent cerebral edema. Even after resolution of diabetic ketoacidosis, the child continued to have pain in the abdomen which necessitated further evaluation. This rare complication of acute pancreatitis was considered, and intravenous fluid and insulin were continued for prolonged duration.
Diabetic ketoacidosis is an absolute insulin deficiency state leading to increased fat mobilization by activating lipolysis in adipose tissue and releasing increased free fatty acids. This accelerates the formation of very low-density lipoprotein (VLDL) in the liver. Reduced activity of lipoprotein lipase in peripheral tissue decreases the removal of VLDL from the plasma, resulting in hypertriglyceridemia. Moderate hypertriglyceridemia is common during episodes of diabetic ketoacidosis. However, severe hypertriglyceridemia is rare, and clinicians should be aware that devastating consequences such as acute pancreatitis or lipidemia retinalis can occur. [3] Review of available literature has shown 12 previous children with severe hyperlipidemia with diabetic ketoacidosis, and acute pancreatitis was present in only eight cases [ Table 2 ]. [3, 4] Our case is the youngest case to present with the triad of severe hyperlipidemia, acute pancreatitis, and diabetic ketoacidosis. The risk of mortality in severe diabetic ketoacidosis is [5] 12.5 >1000 Hydration and insulin 7 Slyper et al., 1994 [6] 14 3119 Hydration and insulin NA Kadota-Shinozaki et al., 1997 [7] 19 3386 Hydration and insulin 2 Hahn et al., 2010 [8] 20
15,000 Hydration and insulin 3 Lutfi et al., 2012 [4] 10 16,334 Plasmapheresis 2 Kota et al., 2012 [9] 12 1020 Hydration and insulin 3 Aboulhosn and Arnason, 2013 [10] 18 1724 Hydration and insulin 3 Wolfgram and Macdonald, 2013 [11] 10 8300 Hydration and insulin much higher in children below 5 years and association with hyperlipidemia, and acute pancreatitis can further increase this risk. Appropriate management includes intravenous fluid and insulin administration according to diabetic ketoacidosis guideline; however, some may require plasmapheresis, especially if having organ failure. [4] A greater degree of clinical monitoring is required as laboratory results are usually delayed and unreliable.
concluSIon
Severe hypertriglyceridemia and acute pancreatitis can be seen with diabetic ketoacidosis in children below 5 years. Early recognition of this triad has important implications in the management of the patient as insulin requirements, recovery duration, and prognosis can be altered.
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